Table 1.
Baseline demographic and tumor profile of 240 breast cancer patients with estrogen receptor-positive tumors
| Tocotrienol + tamoxifen (n = 120) |
Tamoxifen only (n = 120) |
P value | |
|---|---|---|---|
| Age (years) | 48.5 (5.2) | 49.1 (5.9) | 0.30 |
| Ethnicity: | |||
| Malay | 50.0 (60) | 46.7 (56) | 0.61 |
| Chinese | 30.0 (36) | 37.5 (45) | 0.22 |
| Indian | 20.0 (24) | 15.8 (19) | 0.40 |
| Stage of breast cancer: | 0.07 | ||
| 1 | 60.8 (73) | 49.2 (59) | |
| 2 | 39.2 (47) | 50.8 (61) | |
| Involvement of lymph node: | |||
| Yes | 58.3 (70) | 62.5 (75) | 0.51 |
| Number of lymph nodes involveda | 1.5 (3.1) | 1.1 (1.9) | 0.15 |
Continuous variables are expressed as means (standard deviations), and categoric variables, as percentages (numbers). aIncludes only patients with lymph node involvement.